One-day protocol for cerebral perfusion reserve with acetazolamide.
暂无分享,去创建一个
Y Yonekura | J Konishi | Y. Yonekura | H. Okazawa | Yoshiharu Yonekura | N. Tamaki | F. Tanaka | K. Ishizu | T. Fujita | J. Konishi | N. Hattori | J. Wang | N Tamaki | H Okazawa | K Ishizu | N Hattori | T Fujita | F Tanaka | J Wang | Junji Konishi | Naoya Hattori | N. Tamaki | Koichi Ishizu | Toru Fujita | Jinyi Wang
[1] Y. Yonekura,et al. Evaluation of a double-injection method for sequential measurement of cerebral blood flow with iodine-123-iodoamphetamine. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] J. Mountz,et al. Regional cerebral blood flow changes in stroke imaged by Tc-99m HMPAO SPECT with corresponding anatomic image comparison. , 1993, Clinical nuclear medicine.
[3] R. Leroy,et al. Comparison of technetium-99m-ECD to Xenon-133 SPECT in normal controls and in patients with mild to moderate regional cerebral blood flow abnormalities. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] A. Nunn,et al. The single-pass cerebral extraction and capillary permeability-surface area product of several putative cerebral blood flow imaging agents. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] A. Thie,et al. 99mTc‐HMPAO‐SPECT With Acetazolamide Challenge to Detect Hemodynamic Compromise in Occlusive Cerebrovascular Disease , 1992, Stroke.
[6] R. Walovitch,et al. Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] H. Matsuda,et al. SPECT Evaluation of Brain Perfusion Reserve by the Acetazolamide Test Using Tc‐99m HMPAO , 1991, Clinical nuclear medicine.
[8] S. Eberl,et al. Use of technetium-HMPAO to demonstrate changes in cerebral blood flow reserve following carotid endarterectomy. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[9] B. Holman,et al. Metabolism of 99mTc-l,l-Ethyl cysteinate dimer in healthy volunteers , 1991, Neuropharmacology.
[10] J. Adams,et al. Inhibiting carbonic anhydrase in brain tissue increases the respiratory response to rebreathing CO2 , 1990, Brain Research.
[11] G Demonceau,et al. Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, Part 2: Biodistribution and brain imaging in humans. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] D. O'leary,et al. Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, Part 1: Pharmacology of technetium-99m ECD in nonhuman primates. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] A. Shields,et al. Cellular sources of thymidine nucleotides: studies for PET. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] O. Schober,et al. Cerebral dynamics of N-isopropyl-(123I)p-iodoamphetamine. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[15] O B Paulson,et al. Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen. , 1984, The Journal of clinical investigation.
[16] A Hauge,et al. Acute effects of acetazolamide on cerebral blood flow in man. , 1983, Acta physiologica Scandinavica.
[17] Hanson Ma,et al. The location of carbonic anhydrase in relation to the blood-brain barrier at the medullary chemoreceptors of the cat. , 1981 .
[18] N. Lassen,et al. Retention of 99mTc-bicisate in the human brain after intracarotid injection. , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[19] N. Sadato,et al. SPECT images of technetium-99m-ethyl cysteinate dimer in cerebrovascular diseases: comparison with other cerebral perfusion tracers and PET. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[20] N. Lassen,et al. Characterization of 99mTc-bicisate as an agent for the measurement of cerebral blood flow with SPECT. , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[21] S. Tanada,et al. Kinetic behavior of technetium-99m-HMPAO in the human brain and quantification of cerebral blood flow using dynamic SPECT. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[22] H. Deininger,et al. [The value of the acetazolamide stimulation test with 99mTc-HMPAO-SPECT in reversible cerebrovascular insufficiency]. , 1991, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.
[23] S. Pauwels,et al. Production of [2-11C]thymidine for quantification of cellular proliferation with PET. , 1991, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.
[24] N. Lassen. Pathophysiology of Brain Ischemia as It Relates to the Therapy of Acute Ischemic Stroke , 1990, Clinical neuropharmacology.
[25] N. Lassen,et al. Cerebral blood-flow tomography: xenon-133 compared with isopropyl-amphetamine-iodine-123: concise communication. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] M. Hanson,et al. The location of carbonic anhydrase in relation to the blood‐brain barrier at the medullary chemoreceptors of the cat. , 1981, The Journal of physiology.
[27] J. Cleaver. Thymidine metabolism and cell kinetics , 1967 .